Avanos Medical Quarterly Balance Sheets Chart
Quarterly
|
Annual
Avanos Medical Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 90,300,000 | 97,000,000 | 107,700,000 | 89,000,000 | 92,200,000 | 75,800,000 | 87,700,000 | 107,100,000 | 81,800,000 | 95,700,000 | 127,700,000 | 117,000,000 | 106,500,000 | 104,300,000 | 118,500,000 | 97,800,000 | 99,900,000 | 100,100,000 | 111,500,000 | 180,000,000 | 185,000,000 | 187,700,000 | 205,300,000 | 214,400,000 | 288,100,000 | 348,300,000 | 384,500,000 | 411,800,000 | 479,600,000 | 203,100,000 | 219,700,000 | 166,100,000 | 154,800,000 | 143,100,000 | 113,700,000 | 86,700,000 | 79,200,000 | 165,100,000 | 129,500,000 | 112,500,000 | 114,300,000 | 166,200,000 | 149,000,000 | 58,400,000 |
accounts receivable | 110,200,000 | 104,800,000 | 132,800,000 | 131,900,000 | 123,000,000 | 131,300,000 | 142,800,000 | 145,200,000 | 152,300,000 | 142,700,000 | 167,900,000 | 146,200,000 | 145,400,000 | 161,600,000 | 118,200,000 | 117,500,000 | 106,700,000 | 105,300,000 | 108,600,000 | 182,300,000 | 137,800,000 | 159,600,000 | 163,800,000 | 157,700,000 | 124,300,000 | 135,000,000 | 150,500,000 | 151,800,000 | 189,200,000 | 199,500,000 | 203,000,000 | 194,400,000 | 184,100,000 | 181,200,000 | 190,100,000 | 189,100,000 | 195,200,000 | 206,300,000 | 224,700,000 | 204,400,000 | 200,100,000 | 226,500,000 | 233,900,000 | 192,200,000 |
inventories | 142,700,000 | 138,100,000 | 138,800,000 | 161,900,000 | 163,900,000 | 165,600,000 | 163,200,000 | 156,600,000 | 148,300,000 | 200,000,000 | 190,300,000 | 193,600,000 | 169,000,000 | 157,600,000 | 150,300,000 | 158,400,000 | 159,700,000 | 165,200,000 | 168,900,000 | 184,100,000 | 174,100,000 | 153,100,000 | 145,900,000 | 144,500,000 | 133,900,000 | 129,600,000 | 121,400,000 | 121,200,000 | 107,800,000 | 92,300,000 | 91,100,000 | 300,500,000 | 296,200,000 | 273,400,000 | 272,500,000 | 298,700,000 | 310,300,000 | 308,400,000 | 303,200,000 | 323,600,000 | 323,900,000 | 293,000,000 | 283,100,000 | 294,700,000 |
prepaid and other current assets | 12,800,000 | 12,500,000 | 14,100,000 | 15,900,000 | 22,300,000 | 28,600,000 | 28,800,000 | 13,600,000 | 15,800,000 | 15,400,000 | 13,900,000 | 13,200,000 | 16,200,000 | 15,700,000 | 18,600,000 | 18,900,000 | 23,500,000 | 57,200,000 | 14,400,000 | 17,200,000 | 18,600,000 | 16,800,000 | ||||||||||||||||||||||
total current assets | 356,000,000 | 352,400,000 | 393,400,000 | 472,600,000 | 474,100,000 | 467,800,000 | 487,000,000 | 524,600,000 | 506,900,000 | 453,800,000 | 499,800,000 | 470,000,000 | 437,100,000 | 439,200,000 | 418,600,000 | 405,000,000 | 443,500,000 | 447,900,000 | 467,200,000 | 567,600,000 | 517,100,000 | 524,100,000 | 538,500,000 | 546,500,000 | 572,500,000 | 660,000,000 | 713,600,000 | 737,200,000 | 876,500,000 | 1,161,100,000 | 1,160,700,000 | 681,000,000 | 654,800,000 | 614,400,000 | 593,500,000 | 605,600,000 | 609,700,000 | 706,600,000 | 676,000,000 | 666,000,000 | 653,100,000 | 703,100,000 | 684,900,000 | 596,100,000 |
property, plant and equipment | 114,300,000 | 109,800,000 | 110,700,000 | 109,500,000 | 110,700,000 | 116,200,000 | 117,200,000 | 116,800,000 | 122,600,000 | 163,500,000 | 163,900,000 | 163,400,000 | 164,300,000 | 166,900,000 | 168,100,000 | 169,700,000 | 171,900,000 | 173,400,000 | 175,300,000 | 177,300,000 | 179,300,000 | 178,700,000 | 184,500,000 | 182,100,000 | 174,400,000 | 159,600,000 | 154,100,000 | 137,000,000 | 123,500,000 | 117,500,000 | 109,900,000 | 261,100,000 | 259,700,000 | 258,300,000 | 260,800,000 | 265,000,000 | 272,600,000 | 275,600,000 | 279,500,000 | 282,100,000 | 286,000,000 | 281,800,000 | 277,800,000 | 292,800,000 |
operating lease right-of-use assets | 31,100,000 | 32,100,000 | 34,100,000 | 26,500,000 | 29,400,000 | 24,200,000 | 26,800,000 | 27,100,000 | 29,100,000 | 28,300,000 | 30,600,000 | 32,500,000 | 33,900,000 | 36,100,000 | 38,600,000 | 41,400,000 | 42,900,000 | 45,100,000 | 56,500,000 | 60,000,000 | 59,900,000 | 64,000,000 | 67,200,000 | 54,900,000 | ||||||||||||||||||||
goodwill | 381,200,000 | 455,900,000 | 455,600,000 | 795,100,000 | 794,400,000 | 794,900,000 | 796,100,000 | 791,500,000 | 762,600,000 | 821,500,000 | 819,400,000 | 823,600,000 | 825,000,000 | 826,000,000 | 801,600,000 | 801,800,000 | 802,600,000 | 802,100,000 | 802,500,000 | 801,200,000 | 800,200,000 | 799,800,000 | 800,900,000 | 800,500,000 | 782,300,000 | 783,700,000 | 783,600,000 | 786,700,000 | 763,800,000 | 764,600,000 | 764,700,000 | 1,032,000,000 | 1,030,900,000 | 1,029,700,000 | 1,029,000,000 | 1,031,900,000 | 1,031,600,000 | 946,800,000 | 945,200,000 | 943,400,000 | 1,422,800,000 | 1,422,100,000 | 1,426,100,000 | 1,429,000,000 |
other intangible assets | 105,400,000 | 107,200,000 | 112,300,000 | 220,100,000 | 226,200,000 | 232,800,000 | 239,500,000 | 242,200,000 | 222,600,000 | 244,700,000 | 251,000,000 | 258,700,000 | 264,900,000 | 271,100,000 | 141,200,000 | 145,300,000 | 149,500,000 | 153,600,000 | 157,700,000 | 170,100,000 | 174,600,000 | 179,300,000 | 184,300,000 | 189,500,000 | 158,500,000 | 163,200,000 | 168,200,000 | 173,900,000 | 139,500,000 | 144,600,000 | 148,900,000 | 154,800,000 | 159,800,000 | 164,400,000 | 169,800,000 | 176,700,000 | 182,400,000 | 77,400,000 | 82,600,000 | 89,000,000 | 95,400,000 | 101,800,000 | 108,300,000 | 116,300,000 |
deferred tax assets | 25,300,000 | 25,000,000 | 24,900,000 | 6,600,000 | 6,300,000 | 6,300,000 | 6,500,000 | 4,300,000 | 4,400,000 | 4,500,000 | 4,600,000 | 10,900,000 | 11,100,000 | 11,300,000 | 10,000,000 | 23,600,000 | 61,900,000 | 15,400,000 | 10,000,000 | 12,000,000 | 14,000,000 | 11,000,000 | 16,100,000 | 12,300,000 | 13,300,000 | 6,200,000 | 6,300,000 | 6,300,000 | 10,600,000 | 11,300,000 | 7,600,000 | 16,300,000 | 16,100,000 | 15,800,000 | 15,100,000 | 12,200,000 | 12,000,000 | 11,300,000 | 14,900,000 | |||||
other assets | 25,700,000 | 25,400,000 | 23,200,000 | 25,800,000 | 16,700,000 | 19,100,000 | 19,300,000 | 18,400,000 | 18,500,000 | 18,600,000 | 17,600,000 | 16,100,000 | 16,500,000 | 15,900,000 | 16,500,000 | 11,100,000 | 11,000,000 | 11,300,000 | 11,800,000 | 14,400,000 | 10,700,000 | 10,900,000 | 11,300,000 | 12,800,000 | 15,200,000 | 6,400,000 | 7,600,000 | 3,400,000 | 3,500,000 | 3,800,000 | 4,100,000 | 3,700,000 | 3,600,000 | 3,800,000 | 3,600,000 | 3,600,000 | 3,700,000 | 2,000,000 | 2,000,000 | 25,800,000 | 28,200,000 | 27,600,000 | 27,900,000 | 15,200,000 |
total assets | 1,039,000,000 | 1,107,800,000 | 1,154,200,000 | 1,656,200,000 | 1,657,800,000 | 1,661,300,000 | 1,692,400,000 | 1,724,900,000 | 1,666,700,000 | 1,734,900,000 | 1,786,900,000 | 1,775,200,000 | 1,752,800,000 | 1,766,500,000 | 1,594,600,000 | 1,597,900,000 | 1,683,300,000 | 1,648,800,000 | 1,672,800,000 | 1,799,100,000 | 1,755,900,000 | 1,763,700,000 | 1,799,600,000 | 1,807,700,000 | 1,783,400,000 | 1,834,000,000 | 1,833,400,000 | 1,844,500,000 | 1,917,400,000 | 2,202,900,000 | 2,195,900,000 | 2,148,900,000 | 2,124,900,000 | 2,086,400,000 | 2,071,800,000 | 2,095,000,000 | 2,112,000,000 | 2,019,700,000 | 2,000,200,000 | 2,006,300,000 | 2,485,500,000 | 2,536,400,000 | 2,527,600,000 | 2,449,400,000 |
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 9,400,000 | 9,400,000 | 9,400,000 | 9,400,000 | 10,200,000 | 9,400,000 | 8,600,000 | 6,200,000 | 6,200,000 | 6,200,000 | 6,200,000 | 6,200,000 | 4,700,000 | 39,800,000 | ||||||||||||||||||||||||||||||
current portion of operating lease liabilities | 10,400,000 | 10,400,000 | 10,900,000 | 13,700,000 | 14,400,000 | 11,500,000 | 12,800,000 | 12,700,000 | 13,500,000 | 12,100,000 | 12,800,000 | 13,400,000 | 13,500,000 | 14,500,000 | 14,700,000 | 14,700,000 | 14,900,000 | 15,100,000 | 15,600,000 | 15,400,000 | 14,300,000 | 14,500,000 | 14,700,000 | 11,700,000 | ||||||||||||||||||||
trade accounts payable | 48,800,000 | 46,000,000 | 54,300,000 | 54,200,000 | 51,400,000 | 57,000,000 | 56,300,000 | 52,100,000 | 65,400,000 | 59,600,000 | 67,900,000 | 62,700,000 | 64,200,000 | 63,800,000 | 56,400,000 | 54,900,000 | 65,500,000 | 59,200,000 | 67,600,000 | 75,900,000 | 75,800,000 | 73,500,000 | 83,000,000 | 94,700,000 | 99,400,000 | 148,800,000 | 169,900,000 | 159,200,000 | 176,900,000 | 194,400,000 | 171,200,000 | 172,500,000 | 184,400,000 | 179,700,000 | 173,100,000 | 166,500,000 | 168,600,000 | 181,100,000 | 163,200,000 | 179,100,000 | 200,600,000 | 192,100,000 | 168,700,000 | 118,400,000 |
accrued expenses | 66,000,000 | 71,400,000 | 91,300,000 | 82,700,000 | 79,500,000 | 75,100,000 | 93,200,000 | 97,200,000 | 72,700,000 | 80,600,000 | 98,900,000 | 80,000,000 | 68,700,000 | 74,600,000 | 68,100,000 | 59,600,000 | 77,900,000 | 80,300,000 | 83,200,000 | 87,900,000 | 84,800,000 | 101,600,000 | 114,800,000 | 108,900,000 | 72,900,000 | 77,900,000 | 94,400,000 | 106,300,000 | 175,900,000 | 128,300,000 | 144,900,000 | 146,900,000 | 137,400,000 | 130,300,000 | 151,300,000 | 144,200,000 | 136,300,000 | 128,200,000 | 152,000,000 | 147,700,000 | 123,400,000 | 145,000,000 | 183,400,000 | 148,600,000 |
total current liabilities | 134,600,000 | 137,200,000 | 165,900,000 | 212,900,000 | 208,200,000 | 205,200,000 | 234,600,000 | 170,700,000 | 160,500,000 | 158,500,000 | 185,800,000 | 162,300,000 | 151,100,000 | 152,900,000 | 139,200,000 | 129,200,000 | 158,300,000 | 154,600,000 | 166,300,000 | 179,400,000 | 176,000,000 | 189,400,000 | 212,500,000 | 218,100,000 | 187,000,000 | 238,400,000 | 264,300,000 | 265,500,000 | 352,800,000 | 360,600,000 | 389,800,000 | 319,400,000 | 321,800,000 | 310,000,000 | 324,400,000 | 310,700,000 | 304,900,000 | 309,300,000 | 315,200,000 | 326,800,000 | 324,000,000 | 341,000,000 | 356,000,000 | 277,900,000 |
long-term debt | 95,700,000 | 98,000,000 | 125,300,000 | 152,600,000 | 164,900,000 | 167,200,000 | 159,400,000 | 258,300,000 | 203,300,000 | 204,700,000 | 226,300,000 | 247,800,000 | 249,300,000 | 254,400,000 | 130,000,000 | 145,000,000 | 165,000,000 | 175,000,000 | 180,000,000 | 248,500,000 | 248,400,000 | 248,200,000 | 248,100,000 | 247,900,000 | 247,800,000 | 247,900,000 | 247,700,000 | 247,600,000 | 247,400,000 | 542,000,000 | 541,100,000 | 580,400,000 | 579,900,000 | 579,400,000 | 579,000,000 | 589,400,000 | 624,000,000 | 578,500,000 | 578,100,000 | 585,900,000 | 585,800,000 | 631,400,000 | 632,300,000 | |
operating lease liabilities | 21,800,000 | 23,100,000 | 24,600,000 | 26,500,000 | 28,800,000 | 26,600,000 | 28,300,000 | 29,500,000 | 30,900,000 | 32,400,000 | 34,700,000 | 36,800,000 | 38,400,000 | 40,000,000 | 42,800,000 | 46,100,000 | 47,500,000 | 50,100,000 | 56,100,000 | 58,900,000 | 58,800,000 | 62,500,000 | 65,500,000 | 57,700,000 | ||||||||||||||||||||
deferred tax liabilities | 6,300,000 | 5,600,000 | 5,500,000 | 23,900,000 | 23,400,000 | 23,600,000 | 23,800,000 | 28,700,000 | 21,800,000 | 25,100,000 | 25,400,000 | 37,000,000 | 34,700,000 | 34,700,000 | 9,600,000 | 5,600,000 | 5,600,000 | 5,600,000 | 5,700,000 | 13,800,000 | 500,000 | 600,000 | 4,400,000 | 4,400,000 | 1,100,000 | 1,000,000 | 18,300,000 | 17,800,000 | 36,500,000 | 36,400,000 | 36,200,000 | 35,800,000 | 63,400,000 | 63,400,000 | 23,900,000 | 23,800,000 | ||||||||
other long-term liabilities | 4,300,000 | 4,500,000 | 4,400,000 | 10,600,000 | 10,500,000 | 10,800,000 | 10,000,000 | 15,600,000 | 15,400,000 | 15,500,000 | 23,500,000 | 27,800,000 | 27,700,000 | 28,000,000 | 9,100,000 | 10,100,000 | 10,600,000 | 10,900,000 | 11,000,000 | 11,400,000 | 11,000,000 | 10,800,000 | 11,200,000 | 11,800,000 | 5,600,000 | 5,500,000 | 19,800,000 | 30,100,000 | 29,600,000 | 30,200,000 | 31,800,000 | 31,900,000 | 30,000,000 | 29,900,000 | 30,100,000 | 30,000,000 | 30,200,000 | 28,200,000 | 27,800,000 | 52,600,000 | 53,900,000 | 52,200,000 | 48,100,000 | |
total liabilities | 262,700,000 | 268,400,000 | 325,700,000 | 426,500,000 | 435,800,000 | 433,400,000 | 456,100,000 | 502,800,000 | 431,900,000 | 436,200,000 | 495,700,000 | 511,700,000 | 501,200,000 | 510,000,000 | 330,700,000 | 336,000,000 | 387,000,000 | 396,200,000 | 416,300,000 | 509,200,000 | 494,300,000 | 507,200,000 | 534,400,000 | 540,800,000 | 506,500,000 | 553,900,000 | 536,200,000 | 544,300,000 | 630,800,000 | 951,100,000 | 980,500,000 | 968,200,000 | 968,100,000 | 955,500,000 | 969,300,000 | 993,500,000 | 1,022,500,000 | 939,900,000 | 944,900,000 | 965,300,000 | 963,700,000 | 1,024,600,000 | 1,036,400,000 | 370,400,000 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par value - authorized 20,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,314,057 outstanding as of june 30, 2025 and 45,962,627 outstanding as of december 31, 2024 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital | 1,686,900,000 | 1,682,800,000 | 1,678,600,000 | 1,674,700,000 | 1,671,500,000 | 1,667,700,000 | 1,663,600,000 | 1,659,700,000 | 1,654,900,000 | 1,651,000,000 | 1,646,400,000 | 1,642,300,000 | 1,637,400,000 | 1,633,300,000 | 1,628,800,000 | 1,625,700,000 | 1,621,300,000 | 1,617,300,000 | 1,609,400,000 | 1,604,100,000 | 1,599,900,000 | 1,596,400,000 | 1,593,900,000 | 1,592,100,000 | 1,586,800,000 | 1,582,500,000 | 1,578,100,000 | 1,575,500,000 | 1,567,700,000 | 1,557,300,000 | 1,550,500,000 | 1,547,400,000 | 1,543,800,000 | 1,538,100,000 | 1,533,200,000 | 1,530,400,000 | 1,527,300,000 | 1,521,700,000 | 1,518,000,000 | 1,517,900,000 | 1,514,300,000 | 1,507,900,000 | 1,502,500,000 | |
accumulated deficit | -777,200,000 | -700,400,000 | -707,000,000 | -309,700,000 | -314,000,000 | -315,800,000 | -314,900,000 | -325,400,000 | -321,700,000 | -253,600,000 | -253,100,000 | -270,000,000 | -293,100,000 | -304,500,000 | -310,300,000 | -320,300,000 | -285,200,000 | -323,100,000 | -315,500,000 | -268,300,000 | -287,600,000 | -284,600,000 | -288,300,000 | -282,200,000 | -270,700,000 | -262,700,000 | -242,400,000 | -240,200,000 | -244,400,000 | -279,700,000 | -299,900,000 | -332,700,000 | -349,300,000 | -366,400,000 | -379,200,000 | -389,200,000 | -398,300,000 | -404,800,000 | ||||||
treasury stock | -101,900,000 | -101,200,000 | -99,000,000 | -98,900,000 | -98,500,000 | -95,000,000 | -85,900,000 | -79,700,000 | -70,500,000 | -67,900,000 | -66,800,000 | -66,400,000 | -55,400,000 | -40,700,000 | -21,300,000 | -10,400,000 | -10,300,000 | -9,800,000 | -9,800,000 | -9,300,000 | -9,200,000 | -8,900,000 | -8,900,000 | -8,700,000 | -8,600,000 | -7,200,000 | -5,300,000 | -5,100,000 | -5,100,000 | -4,500,000 | -4,400,000 | -3,900,000 | -3,900,000 | -1,900,000 | -1,900,000 | -1,900,000 | -1,900,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | |||
accumulated other comprehensive loss | -32,000,000 | -42,300,000 | -44,600,000 | -36,900,000 | -37,500,000 | -29,500,000 | -27,000,000 | -33,000,000 | -28,400,000 | -31,300,000 | -35,800,000 | -42,900,000 | -37,800,000 | -32,100,000 | -33,800,000 | -33,600,000 | -30,000,000 | -32,300,000 | -28,100,000 | -37,100,000 | -42,000,000 | -46,900,000 | -32,000,000 | -34,800,000 | -31,100,000 | -33,000,000 | -33,700,000 | -30,500,000 | -32,100,000 | -21,800,000 | -31,300,000 | -30,600,000 | -34,300,000 | -39,400,000 | -50,100,000 | -38,300,000 | -38,100,000 | -36,600,000 | -43,200,000 | -42,800,000 | -28,900,000 | -25,600,000 | -21,100,000 | |
total stockholders’ equity | 776,300,000 | 839,400,000 | 828,500,000 | 1,229,700,000 | 1,222,000,000 | 1,227,900,000 | 1,236,300,000 | 1,222,100,000 | 1,234,800,000 | 1,298,700,000 | 1,291,200,000 | 1,263,500,000 | 1,251,600,000 | 1,256,500,000 | 1,263,900,000 | 1,261,900,000 | 1,296,300,000 | 1,252,600,000 | 1,256,500,000 | 1,289,900,000 | 1,261,600,000 | 1,256,500,000 | 1,265,200,000 | 1,266,900,000 | 1,276,900,000 | 1,280,100,000 | 1,297,200,000 | 1,300,200,000 | 1,286,600,000 | 1,251,800,000 | 1,215,400,000 | 1,180,700,000 | 1,156,800,000 | 1,130,900,000 | 1,102,500,000 | 1,101,500,000 | 1,089,500,000 | 1,079,800,000 | 1,055,300,000 | 1,041,000,000 | 1,521,800,000 | 1,511,800,000 | 1,491,200,000 | |
total liabilities and stockholders’ equity | 1,039,000,000 | 1,107,800,000 | 1,154,200,000 | 1,656,200,000 | 1,657,800,000 | 1,661,300,000 | 1,692,400,000 | 1,724,900,000 | 1,666,700,000 | 1,734,900,000 | 1,786,900,000 | 1,775,200,000 | 1,752,800,000 | 1,766,500,000 | 1,594,600,000 | 1,597,900,000 | 1,683,300,000 | 1,648,800,000 | 1,672,800,000 | 1,799,100,000 | 1,755,900,000 | 1,763,700,000 | 1,799,600,000 | 1,807,700,000 | 1,783,400,000 | 1,834,000,000 | 1,833,400,000 | 1,844,500,000 | 1,917,400,000 | 2,202,900,000 | 2,195,900,000 | 2,148,900,000 | 2,124,900,000 | 2,086,400,000 | 2,071,800,000 | 2,095,000,000 | 2,112,000,000 | 2,019,700,000 | 2,000,200,000 | 2,006,300,000 | 2,485,500,000 | 2,536,400,000 | 2,527,600,000 | |
common stock - 0.01 par value - authorized 300,000,000 shares, 46,236,444 outstanding as of march 31, 2025 and 45,962,627 outstanding as of december 31, 2024 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 73,900,000 | 72,700,000 | 66,500,000 | 64,500,000 | 102,100,000 | 108,700,000 | 650,400,000 | 632,500,000 | 2,600,000 | |||||||||||||||||||||||||||||||||||
liabilities held for sale | 52,900,000 | 52,700,000 | 52,200,000 | 63,700,000 | 2,500,000 | 2,700,000 | 37,900,000 | 33,900,000 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 45,962,627 outstanding at december 31, 2024 and 46,174,337 outstanding at december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of september 30, 2024 and 46,174,337 outstanding as of december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 45,913,043 outstanding as of june 30, 2024 and 46,174,337 outstanding as of december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,066,997 outstanding as of march 31, 2024 and 46,174,337 outstanding as of december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,174,337 outstanding at december 31, 2023 and 46,528,907 outstanding at december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,425,157 outstanding as of september 30, 2023 and 46,528,907 outstanding as of december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,832,847 outstanding as of june 30, 2023 and 46,528,907 outstanding as of december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,660,199 outstanding as of march 31, 2023 and 46,528,907 outstanding as of december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,528,907 outstanding at december 31, 2022 and 48,206,156 outstanding at december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,495,519 outstanding as of september 30, 2022 and 48,206,156 outstanding as of december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,849,951 outstanding as of june 30, 2022 and 48,206,156 outstanding as of december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,324,093 outstanding as of march 31, 2022 and 48,206,156 outstanding as of december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
income tax receivable | 13,000,000 | 11,600,000 | 58,400,000 | 59,000,000 | 59,300,000 | |||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,206,156 outstanding at december 31, 2021 and 47,917,583 outstanding at december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 19,700,000 | 18,800,000 | 18,300,000 | 21,200,000 | 20,200,000 | 23,700,000 | 29,900,000 | 26,200,000 | 47,100,000 | 52,400,000 | 48,400,000 | 15,800,000 | 20,000,000 | 19,700,000 | 16,700,000 | 31,100,000 | 25,000,000 | 26,800,000 | ||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,128,749 outstanding as of september 30, 2021 and 47,917,583 outstanding as of december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,095,484 outstanding as of june 30, 2021 and 47,917,583 outstanding as of december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,059,819 outstanding as of march 31, 2021 and 47,917,583 outstanding as of december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
operating lease right of use assets | 48,300,000 | 64,000,000 | ||||||||||||||||||||||||||||||||||||||||||
current portion of operating lease obligation | 15,500,000 | 14,700,000 | ||||||||||||||||||||||||||||||||||||||||||
operating lease obligation | 53,300,000 | 62,600,000 | ||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,917,583 outstanding at december 31, 2020 and 47,734,206 outstanding at december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,833,115 outstanding as of september 30, 2020 and 47,734,206 outstanding as of december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,802,185 outstanding as of june 30, 2020 and 47,734,206 outstanding as of december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,755,911 outstanding as of march 31, 2020 and 47,734,206 outstanding as of december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,734,206 outstanding at december 31, 2019 and 47,444,340 outstanding at december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,719,954 outstanding as of september 30, 2019 and 47,444,340 outstanding as of december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,653,527 outstanding as of june 30, 2019 and 47,444,340 outstanding as of december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,504,680 outstanding as of march 31, 2019 and 47,444,340 outstanding as of december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,444,340 outstanding at december 31, 2018 and 46,920,076 outstanding at december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,426,996 outstanding as of september 30, 2018 and 46,920,076 outstanding as of december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
restricted cash | 51,500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,279,645 outstanding as of june 30, 2018 and 46,920,076 outstanding as of december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,014,536 outstanding as of march 31, 2018 and 46,920,076 outstanding as of december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,920,076 outstanding at december 31, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,835,044 outstanding as of september 30, 2017 and 46,681,798 outstanding as of december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,791,748 outstanding at june 30, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,695,242 outstanding at march 31, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,681,798 outstanding at december 31, 2016 and 46,614,947 outstanding at december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,674,183 outstanding at september 30, 2016 and 46,614,947 outstanding at december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,670,129 outstanding at june 30, 2016 and 46,614,947 outstanding at december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,614,947 outstanding at march 31, 2016 and december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
current deferred income taxes | 2,100,000 | |||||||||||||||||||||||||||||||||||||||||||
debt payable within one year | 3,900,000 | 3,900,000 | 10,900,000 | |||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,614,947 outstanding at december 31, 2015 and 46,535,951 outstanding at december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
(accumulated deficit) retained earnings | -419,000,000 | -433,600,000 | ||||||||||||||||||||||||||||||||||||||||||
current deferred income taxes and other current assets | 25,500,000 | 14,800,000 | 17,400,000 | 50,800,000 | ||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,613,982 outstanding as of september 30, 2015 and 46,535,951 as of december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,605,790 outstanding as of june 30, 2015 and 46,535,951 as of december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
retained earnings | 36,900,000 | 29,000,000 | 7,300,000 | |||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,535,951 outstanding as of march 31, 2015 and december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
liabilities and equity | ||||||||||||||||||||||||||||||||||||||||||||
related party debt | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock—0.01 par value—authorized 20,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||
common stock—0.01 par value—authorized 300,000,000 shares in 2014; 46,535,951 outstanding at december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
kimberly-clark’s net investment | ||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -19,100,000 | |||||||||||||||||||||||||||||||||||||||||||
liabilities and invested equity | ||||||||||||||||||||||||||||||||||||||||||||
long-term liabilities | 92,500,000 | |||||||||||||||||||||||||||||||||||||||||||
invested equity | ||||||||||||||||||||||||||||||||||||||||||||
kimberly-clark's net investment | 2,100,100,000 | |||||||||||||||||||||||||||||||||||||||||||
total invested equity | 2,079,000,000 | |||||||||||||||||||||||||||||||||||||||||||
total liabilities and invested equity | 2,449,400,000 | |||||||||||||||||||||||||||||||||||||||||||
operating activities | ||||||||||||||||||||||||||||||||||||||||||||
net income | 29,500,000 | |||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 61,600,000 | |||||||||||||||||||||||||||||||||||||||||||
share-based compensation charged by kimberly-clark | 5,100,000 | |||||||||||||||||||||||||||||||||||||||||||
benefit from losses on accounts receivable and inventories | 100,000 | |||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | -13,900,000 | |||||||||||||||||||||||||||||||||||||||||||
asset impairment | 41,900,000 | |||||||||||||||||||||||||||||||||||||||||||
net incomees on asset dispositions | 3,500,000 | |||||||||||||||||||||||||||||||||||||||||||
changes in operating working capital: | ||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable | 10,900,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in inventories | -9,100,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in trade accounts payable | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||
decrease in accrued expenses | -23,600,000 | |||||||||||||||||||||||||||||||||||||||||||
decrease in accrued income taxes | -3,900,000 | |||||||||||||||||||||||||||||||||||||||||||
other | -1,800,000 | |||||||||||||||||||||||||||||||||||||||||||
cash from operating activities | 107,300,000 | |||||||||||||||||||||||||||||||||||||||||||
investing activities | ||||||||||||||||||||||||||||||||||||||||||||
capital spending | -60,400,000 | |||||||||||||||||||||||||||||||||||||||||||
cash outflows for acquisitions and investments | ||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities | -60,400,000 | |||||||||||||||||||||||||||||||||||||||||||
financing activities | ||||||||||||||||||||||||||||||||||||||||||||
debt proceeds | 1,900,000 | |||||||||||||||||||||||||||||||||||||||||||
debt repayments | -2,900,000 | |||||||||||||||||||||||||||||||||||||||||||
change in kimberly-clark's net investment | -34,800,000 | |||||||||||||||||||||||||||||||||||||||||||
cash from financing activities | -32,400,000 | |||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | -200,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents | 14,300,000 | |||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning of period | 44,100,000 | |||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of period | 58,400,000 |
We provide you with 20 years of balance sheets for Avanos Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Avanos Medical. Explore the full financial landscape of Avanos Medical stock with our expertly curated balance sheets.
The information provided in this report about Avanos Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.